Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial
| العنوان: | Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial |
|---|---|
| المؤلفون: | Caroline P. E. Price, Amina Guo, Whitney W. Stevens, Leslie Cousens, Thanh‐Huyen T. Vu, Lydia A. Suh, Kristin A. Erickson, David Conley, Leslie C. Grammer, Robert C. Kern, Bruce K. Tan, Atsushi Kato, Robert P. Schleimer, Stephanie S. Smith, Kevin C. Welch, Anju T. Peters |
| المصدر: | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyREFERENCES. 52(7) |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Adult, Indoles, Immunology, Acetates, Immunity, Innate, Nasal Polyps, Adrenal Cortex Hormones, Chronic Disease, Quality of Life, Immunology and Allergy, Humans, Lymphocytes, Sinusitis, Rhinitis |
| الوصف: | Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease of the upper airways. AZD1981 is a selective antagonist of chemoattractant receptor-homologous molecule expressed on T helper type 2 and other type 2 cells, including innate lymphoid cells type 2, eosinophils, and basophils.To evaluate the efficacy of AZD1981 in reducing nasal polyp size when added to intranasal corticosteroids in adult patients with CRSwNP.Eighty-one subjects (18-70 years of age) with CRSwNP were recruited and screened for trial eligibility from allergy and otolaryngology clinics from a single tertiary care site between June 2016 and August 2019. Eligible patients were randomized in a double-blind fashion to receive either AZD1981 (n = 22) or placebo (n = 21) orally three times a day for 12 weeks, added to intranasal corticosteroids. The primary endpoint was a change in nasal polyp score (NPS) at 12 weeks. Secondary endpoints included improvement in sinus computed tomography using Lund Mackay scoring, symptoms using visual analog scale, quality of life using Sino Nasal Outcome Test-22, and the Brief Smell Identification Test.Forty-three patients met the inclusion criteria and were enrolled. At 12 weeks, there was no difference in NPS change in the AZD1981 arm (mean 0, standard error 0.34, n = 15) compared with placebo (mean 0.20, standard error 0.36, n = 17); mean difference -0.20 (95% confidence interval: -1.21, 0.81; p = .69). No significant differences were observed for Lund Mackay score, symptoms, quality of life, or smell test. AZD1981 was well tolerated except for one case of hypersensitivity reaction.In patients with CRSwNP, the addition of AZD1981 to intranasal corticosteroids did not change nasal polyp size, radiographic scores, symptoms, or disease-specific quality of life. |
| تدمد: | 1365-2222 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b544dfe214d8ec17b40291d457bb067aTest https://pubmed.ncbi.nlm.nih.gov/35524339Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....b544dfe214d8ec17b40291d457bb067a |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi.dedup.....b544dfe214d8ec17b40291d457bb067a 880 3 unknown 880.388549804688 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b544dfe214d8ec17b40291d457bb067a&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
|
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Caroline+P%2E+E%2E+Price%22">Caroline P. E. Price</searchLink><br /><searchLink fieldCode="AR" term="%22Amina+Guo%22">Amina Guo</searchLink><br /><searchLink fieldCode="AR" term="%22Whitney+W%2E+Stevens%22">Whitney W. Stevens</searchLink><br /><searchLink fieldCode="AR" term="%22Leslie+Cousens%22">Leslie Cousens</searchLink><br /><searchLink fieldCode="AR" term="%22Thanh‐Huyen+T%2E+Vu%22">Thanh‐Huyen T. Vu</searchLink><br /><searchLink fieldCode="AR" term="%22Lydia+A%2E+Suh%22">Lydia A. Suh</searchLink><br /><searchLink fieldCode="AR" term="%22Kristin+A%2E+Erickson%22">Kristin A. Erickson</searchLink><br /><searchLink fieldCode="AR" term="%22David+Conley%22">David Conley</searchLink><br /><searchLink fieldCode="AR" term="%22Leslie+C%2E+Grammer%22">Leslie C. Grammer</searchLink><br /><searchLink fieldCode="AR" term="%22Robert+C%2E+Kern%22">Robert C. Kern</searchLink><br /><searchLink fieldCode="AR" term="%22Bruce+K%2E+Tan%22">Bruce K. Tan</searchLink><br /><searchLink fieldCode="AR" term="%22Atsushi+Kato%22">Atsushi Kato</searchLink><br /><searchLink fieldCode="AR" term="%22Robert+P%2E+Schleimer%22">Robert P. Schleimer</searchLink><br /><searchLink fieldCode="AR" term="%22Stephanie+S%2E+Smith%22">Stephanie S. Smith</searchLink><br /><searchLink fieldCode="AR" term="%22Kevin+C%2E+Welch%22">Kevin C. Welch</searchLink><br /><searchLink fieldCode="AR" term="%22Anju+T%2E+Peters%22">Anju T. Peters</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyREFERENCES</i>. 52(7) ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Indoles%22">Indoles</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology%22">Immunology</searchLink><br /><searchLink fieldCode="DE" term="%22Acetates%22">Acetates</searchLink><br /><searchLink fieldCode="DE" term="%22Immunity%2C+Innate%22">Immunity, Innate</searchLink><br /><searchLink fieldCode="DE" term="%22Nasal+Polyps%22">Nasal Polyps</searchLink><br /><searchLink fieldCode="DE" term="%22Adrenal+Cortex+Hormones%22">Adrenal Cortex Hormones</searchLink><br /><searchLink fieldCode="DE" term="%22Chronic+Disease%22">Chronic Disease</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+Life%22">Quality of Life</searchLink><br /><searchLink fieldCode="DE" term="%22Immunology+and+Allergy%22">Immunology and Allergy</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Lymphocytes%22">Lymphocytes</searchLink><br /><searchLink fieldCode="DE" term="%22Sinusitis%22">Sinusitis</searchLink><br /><searchLink fieldCode="DE" term="%22Rhinitis%22">Rhinitis</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease of the upper airways. AZD1981 is a selective antagonist of chemoattractant receptor-homologous molecule expressed on T helper type 2 and other type 2 cells, including innate lymphoid cells type 2, eosinophils, and basophils.To evaluate the efficacy of AZD1981 in reducing nasal polyp size when added to intranasal corticosteroids in adult patients with CRSwNP.Eighty-one subjects (18-70 years of age) with CRSwNP were recruited and screened for trial eligibility from allergy and otolaryngology clinics from a single tertiary care site between June 2016 and August 2019. Eligible patients were randomized in a double-blind fashion to receive either AZD1981 (n = 22) or placebo (n = 21) orally three times a day for 12 weeks, added to intranasal corticosteroids. The primary endpoint was a change in nasal polyp score (NPS) at 12 weeks. Secondary endpoints included improvement in sinus computed tomography using Lund Mackay scoring, symptoms using visual analog scale, quality of life using Sino Nasal Outcome Test-22, and the Brief Smell Identification Test.Forty-three patients met the inclusion criteria and were enrolled. At 12 weeks, there was no difference in NPS change in the AZD1981 arm (mean 0, standard error 0.34, n = 15) compared with placebo (mean 0.20, standard error 0.36, n = 17); mean difference -0.20 (95% confidence interval: -1.21, 0.81; p = .69). No significant differences were observed for Lund Mackay score, symptoms, quality of life, or smell test. AZD1981 was well tolerated except for one case of hypersensitivity reaction.In patients with CRSwNP, the addition of AZD1981 to intranasal corticosteroids did not change nasal polyp size, radiographic scores, symptoms, or disease-specific quality of life. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1365-2222 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b544dfe214d8ec17b40291d457bb067a" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b544dfe214d8ec17b40291d457bb067a</link><br /><link linkTarget="URL" linkTerm="https://pubmed.ncbi.nlm.nih.gov/35524339" linkWindow="_blank">https://pubmed.ncbi.nlm.nih.gov/35524339</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....b544dfe214d8ec17b40291d457bb067a ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Adult
[Type] => general
)
[1] => Array
(
[SubjectFull] => Indoles
[Type] => general
)
[2] => Array
(
[SubjectFull] => Immunology
[Type] => general
)
[3] => Array
(
[SubjectFull] => Acetates
[Type] => general
)
[4] => Array
(
[SubjectFull] => Immunity, Innate
[Type] => general
)
[5] => Array
(
[SubjectFull] => Nasal Polyps
[Type] => general
)
[6] => Array
(
[SubjectFull] => Adrenal Cortex Hormones
[Type] => general
)
[7] => Array
(
[SubjectFull] => Chronic Disease
[Type] => general
)
[8] => Array
(
[SubjectFull] => Quality of Life
[Type] => general
)
[9] => Array
(
[SubjectFull] => Immunology and Allergy
[Type] => general
)
[10] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[11] => Array
(
[SubjectFull] => Lymphocytes
[Type] => general
)
[12] => Array
(
[SubjectFull] => Sinusitis
[Type] => general
)
[13] => Array
(
[SubjectFull] => Rhinitis
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Caroline P. E. Price
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Amina Guo
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Whitney W. Stevens
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Leslie Cousens
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Thanh‐Huyen T. Vu
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lydia A. Suh
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kristin A. Erickson
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => David Conley
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Leslie C. Grammer
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Robert C. Kern
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bruce K. Tan
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Atsushi Kato
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Robert P. Schleimer
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Stephanie S. Smith
)
)
)
[14] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kevin C. Welch
)
)
)
[15] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Anju T. Peters
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 12
[M] => 04
[Type] => published
[Y] => 2022
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 13652222
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 52
)
[1] => Array
(
[Type] => issue
[Value] => 7
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Clinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyREFERENCES
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |